FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033649053> ?p ?o ?g. }

• W3033649053 abstract "Abstract Background and Aims Disturbances in calcium-phosphate homeostasis are common after kidney transplantation. The clinical implications of changes in calcium-phosphate homeostasis after transplantation are unclear. The aim of this study was to assess the relationship between time-updated serum calcium and phosphate levels and subsequent graft and patient outcomes. Method Kidney transplant recipients with ≥2 serum calcium and phosphate measurements were included from a large single-center cohort; only first transplants were considered. Patients with graft failure &lt;3 months were excluded, as were measurements obtained when eGFR was &lt;15 mL/min/1.73m2 or during intensive care unit admission. Normocalcemia was defined as (albumin-corrected) calcium between 2.20 and 2.60 mmol/L (8.8-10.4 mg/dL), and normophosphatemia as 0.70-1.50 mmol/L (2.17-4.64 mg/dL). Time-updated multivariable Cox regression analyses and time-updated restricted cubic splines analyses were performed to assess the relationship between post-KTx serum corrected calcium and phosphate levels and mortality and death-censored graft failure (DCGF). Final models were adjusted for recipient age, sex, BMI, eGFR, proteinuria, systolic BP (all time-updated), antihypertensive drug use, recipient CMV status, donor age, sex, and status (living or post-mortal), cold and warm ischemia times, HLA mismatches, primary kidney disease, and serum phosphate (in calcium analyses) or corrected calcium (in phosphate analyses). Results A total of 2,769 patients with 138,496 serum corrected calcium and phosphate levels post-KTx were included (median [IQR] 43 [31-61] measurements per patient). Mean age was 47 ± 14 yrs, 42.3% was female, and 19% underwent a pre-emptive transplantation. Hypercalcemia was more common in the first year (15%) and declined to ∼5% during long-term follow-up; hypocalcemia occurred in ∼10% throughout. Hypophosphatemia (24.3%) and hyperphosphatemia (15.5%) were particularly common during the first 30 days post-transplant, and stabilized at ∼10% and ∼5% after the first year. During median follow-up of 16.3 (8.7 – 25.2) years, 477 patients (17.2%) developed DCGF and 1050 (37.9%) patients died. In multivariable regression analyses, post-transplant hypocalcaemia was associated with an increased risk of DCGF (fully adjusted hazard ratio [HR] 2.01 [95% CI 1.61-2.50], P&lt;0.0001; Figure 1A), but not mortality (HR 1.06 [95% CI 0.88-1.27], P=0.55; Figure 1B). Post-transplant hypercalcaemia was associated with an increased risk of mortality (HR 1.77 [95% CI 1.44-2.17], P&lt;0.0001), but not DCGF (HR 0.79 [95% CI 0.48-1.32], P=0.37). Patients with post-KTx hyperphosphatemia were at increased risk of both DCGF (HR 37.12 [95% CI 30.33-45.42], P&lt;0.0001; Figure 1C) and mortality (HR 3.17 [95% CI 1.65-3.86], P&lt;0.0001; Figure 1D). Patients with hypophosphataemia had a lower risk of developing DCGF (HR 0.48 [95% CI 0.28-0.81], P&lt;0.01), but not mortality (HR 0.92 [95% CI 0.72-1.18], P=0.42). Similar results were obtained in sensitivity analyses in a subgroup with parathyroid hormone data available (N=1,412) or after exclusion of the highest and lowest 0.5% of calcium or phosphate levels. Conclusion Post-transplant hypocalcaemia and hyperphosphatemia are associated with an increased risk of DCGF, while hypophosphataemia was linked with a lower DCGF risk. Hypercalcaemia and hyperphosphataemia were associated with an increased mortality risk. These findings underline the relevance of keeping calcium and phosphate within normal range after kidney transplantation." @default.
• W3033649053 created "2020-06-12" @default.
• W3033649053 creator A5001204318 @default.
• W3033649053 creator A5011357193 @default.
• W3033649053 creator A5024862063 @default.
• W3033649053 creator A5038949732 @default.
• W3033649053 creator A5045731739 @default.
• W3033649053 creator A5077283308 @default.
• W3033649053 date "2020-06-01" @default.
• W3033649053 modified "2023-09-26" @default.
• W3033649053 title "P1634TIME-UPDATED SERUM CALCIUM AND PHOSPHATE ARE ASSOCIATED WITH GRAFT AND PATIENT OUTCOMES AFTER KIDNEY TRANSPLANTATION" @default.
• W3033649053 doi "https://doi.org/10.1093/ndt/gfaa142.p1634" @default.
• W3033649053 hasPublicationYear "2020" @default.
• W3033649053 type Work @default.
• W3033649053 sameAs 3033649053 @default.
• W3033649053 citedByCount "0" @default.
• W3033649053 crossrefType "journal-article" @default.
• W3033649053 hasAuthorship W3033649053A5001204318 @default.
• W3033649053 hasAuthorship W3033649053A5011357193 @default.
• W3033649053 hasAuthorship W3033649053A5024862063 @default.
• W3033649053 hasAuthorship W3033649053A5038949732 @default.
• W3033649053 hasAuthorship W3033649053A5045731739 @default.
• W3033649053 hasAuthorship W3033649053A5077283308 @default.
• W3033649053 hasBestOaLocation W30336490531 @default.
• W3033649053 hasConcept C126322002 @default.
• W3033649053 hasConcept C126894567 @default.
• W3033649053 hasConcept C134018914 @default.
• W3033649053 hasConcept C141071460 @default.
• W3033649053 hasConcept C2778653478 @default.
• W3033649053 hasConcept C2780303639 @default.
• W3033649053 hasConcept C2911091166 @default.
• W3033649053 hasConcept C50382708 @default.
• W3033649053 hasConcept C519063684 @default.
• W3033649053 hasConcept C71924100 @default.
• W3033649053 hasConcept C87975464 @default.
• W3033649053 hasConcept C90924648 @default.
• W3033649053 hasConceptScore W3033649053C126322002 @default.
• W3033649053 hasConceptScore W3033649053C126894567 @default.
• W3033649053 hasConceptScore W3033649053C134018914 @default.
• W3033649053 hasConceptScore W3033649053C141071460 @default.
• W3033649053 hasConceptScore W3033649053C2778653478 @default.
• W3033649053 hasConceptScore W3033649053C2780303639 @default.
• W3033649053 hasConceptScore W3033649053C2911091166 @default.
• W3033649053 hasConceptScore W3033649053C50382708 @default.
• W3033649053 hasConceptScore W3033649053C519063684 @default.
• W3033649053 hasConceptScore W3033649053C71924100 @default.
• W3033649053 hasConceptScore W3033649053C87975464 @default.
• W3033649053 hasConceptScore W3033649053C90924648 @default.
• W3033649053 hasLocation W30336490531 @default.
• W3033649053 hasOpenAccess W3033649053 @default.
• W3033649053 hasPrimaryLocation W30336490531 @default.
• W3033649053 hasRelatedWork W10280252 @default.
• W3033649053 hasRelatedWork W10993663 @default.
• W3033649053 hasRelatedWork W11308225 @default.
• W3033649053 hasRelatedWork W1444819 @default.
• W3033649053 hasRelatedWork W15612578 @default.
• W3033649053 hasRelatedWork W19926801 @default.
• W3033649053 hasRelatedWork W3961910 @default.
• W3033649053 hasRelatedWork W4978709 @default.
• W3033649053 hasRelatedWork W8064881 @default.
• W3033649053 hasRelatedWork W8848305 @default.
• W3033649053 isParatext "false" @default.
• W3033649053 isRetracted "false" @default.
• W3033649053 magId "3033649053" @default.
• W3033649053 workType "article" @default.